Cutting edge: High-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury

Journal of Immunology

Volumn 176, Issue 12, 2006, Pages 7154-7158

  Izuishi, Kunihiko ^a   Tsung, Allan ^a   Jeyabalan, Geetha ^a   Critchlow, Nathan D ^a   Li, Jianhua ^c   Tracey, Kevin J ^e   Demarco, Richard A ^a   Lotze, Michael T ^a   Fink, Mitchell P ^a,b   Geller, David A ^a   Billiar, Timothy R ^a,d  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^d PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE M; PHOSPHOTRANSFERASE; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVITY; HELA CELL; HUMAN; HUMAN CELL; INFLAMMATION; ISCHEMIC PRECONDITIONING; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; MALE; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 33744932946     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.12.7154     Document Type: Article

References (27)

1. Fondevila, C., R. W. Busuttil, and J. W. Kupiec-Weglinski. 2003. Hepatic ischemia/reperfusion injury; a fresh look. Exp. Mol. Pathol. 74: 86-93.
2. Selzner, N., H. Rudiger, R. Graf, and P. A. Clavien. 2003. Protective strategies against ischemic injury of the liver. Gastroenterology 125: 917-936.
3. Tsung, A., R. Sahai, H. Tanaka, A. Nakao, M. P. Fink, M. T. Lotze, H. Yang, J. Li, K. J. Tracey, D. A. Geller, and T. R. Billiar. 2005. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J. Exp. Med. 201: 1135-1143.
4. Yotov, W. V., and R. St-Arnaud. 1992. Nucleotide sequence of a mouse cDNA encoding the nonhistone chromosomal high mobility group protein-1 (HMG1). Nucleic Acids Res. 20: 3516.
5. Andersson, U., H. Wang, K. Palmblad, A. C. Aveberger, O. Bloom, H. Erlandsson-Harris, A. Janson, R. Kokkola, M. Zhang, H. Yang, and K. J. Tracey. 2000. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192: 565-570.
6. Liu, S., D. B. Stolz, P. L. Sappington, C. A. Macia, M. E. Killeen, J. J. Tenhunen, R. L. Delude, and M. P. Fink. 2006. HMGB1 is secreted by immunostimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayers. Am. J. Physiol. 290: C990-C999.
7. Degryse, B., T. Bonaldi, P. Scaffidi, S. Muller, M. Resnati, F. Sanvito, G. Arrigoni, and M. E. Bianchi. 2001. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol. 152: 1197-1206.
8. Scaffidi, P., T. Misteli, and M. E. Bianchi. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195.
9. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
10. Greisman, S. E., E. J. Young, and F. A. J. Catozza. 1969. Mechanisms of endotoxin tolerance: specificity of the early and late phases of pyrogenic tolerance. J. Immunol. 103: 1223-1236.
11. Yang, H., M. Ochani, J. Li, X. Qiang, M. Tanovic, H. E. Harris, S. M. Susarla, L. Ulloa, H. Wang, R. DiRaimo, et al. 2004. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. USA 101: 296-301.
12. Colletti, L. M., S. L. Kunkel, A. Walz, M. D. Burdick, R. G. Kunkel, C. A. Wilke, and R. M. Stricter. 1996. The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology 23: 506-514.
13. Wanner, G. A., P. E. Muller, W. Ertel, M. Bauer, M. D. Menger, and K. Messmer. 1999. Differential effect of anti-TNF-α antibody on proinflammatory cytokine release by Kupffet cells following liver ischemia and reperfusion. Shock 11: 391-395.
14. Yoshidome, H., A. Kato, M. J. Edwards, and A. B. Lentsch. 1999. Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implications of a central role for nuclear factor κB. Hepatology 30: 203-208.
15. Hitano, E., B. L. Bennett, A. M. Manning, T. Qian, J. J. Lemasters, and D. A. Brenner. 2001. NF-κB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-α- and Fas-mediated apoptosis. Gastroenterology 120: 1251-1262.
16. Iimuto, Y., T. Nishiura, C. Hellerbrand, K. E. Behrns, R. Schoonhoven, J. W. Grisham, and D. A. Brenner. 1998. NFκB prevents apoptosis and liver dysfunction during liver regeneration. J. Clin. Invest. 101: 802-811.
17. Takahashi, Y., R. W. Ganster, A. Gamborto, L. Shao, T. Kaizu, T. Wu, G. P. Yagnik, A. Nakao, G. Tsoulfas, T. Ishikawa, et al. 2002. Role of NF-κB on liver cold ischemia-reperfusion injury. Am. J. Physiol. 283: G1175-G1184.
18. Park, J. S., D. Sverkauskaite, Q. He, J. Y. Kim, D. Strassheim, A. Ishizaka, and E. Abraham. 2004. Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279: 7370-7377.
19. Park, J. S., F. Gamboni-Robertson, Q. He, D. Swetkauskaite, J. Y. Kim, D. Strassheim, J. W. Sohn, S. Yamada, I. Maruyama, A. Banerjee, et al. 2006. High Mobility Group Box 1 protein (HMGB1) interacts with multiple Toll like receptors. Am. J. Physiol. 290: C917-C924.
20. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
21. Termeer, C., F. Benedix, J. Sleeman, C. Fieber, U. Voith, T. Ahrens, K. Miyake, M. Freudenberg, C. Galanos, and J. C. Simon. 2002. Oligosaccharides of Hyaluronan activate dendritic cells via Toll-like receptor 4. J. Exp. Med. 195: 99-111.
22. Johnson, G. B., G. J. Brunn, Y. Kodaira, and J. L. Platt. 2002. Receptor-mediated monitoring of tissue well-being via detection of soluble hepatan sulfate by Toll-like receptor 4. J. Immunol. 168: 5233-5239.
23. Smiley, S. T., J. A. King, and W. W. Hancock. 2001. Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J. Immunol. 167: 2887-2894.
24. Vabulas, R. M., P. Ahmad-Nejad, S. Ghose, C. J. Kirschning, R. D. Issels, and H. Wagnet. 2002. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem. 277: 15107-15112.
25. Kobayashi, K., L. D. Hernandez, J. E. Galan, C. A. Janeway, R. Medzhitov, and R. A. Flavell. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110: 191-202.
26. Cao, Z., J. Henzel, and X. Gao. 1996. IRAK: a kinase associated with the interleukin-1 receptor. Science 271: 1128-1131.
27. Zhai, Y., X. D. Shen, R. O'Connell, F. Gao, C. Lassman, R. W. Busuttil, G. Cheng, and J. W. Kupiec-Weglinski. 2004. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J. Immunol. 173: 7115-7119.